{"id":59,"date":"2017-03-31T20:46:27","date_gmt":"2017-03-31T18:46:27","guid":{"rendered":"http:\/\/zfbweb.zfb.fuw.edu.pl\/?p=59"},"modified":"2017-06-13T14:04:33","modified_gmt":"2017-06-13T12:04:33","slug":"kolejny-testowy-wpis","status":"publish","type":"post","link":"https:\/\/zfbweb.zfb.fuw.edu.pl\/index.php\/2017\/03\/31\/kolejny-testowy-wpis\/","title":{"rendered":"ESTRO 36 in Vienna in May"},"content":{"rendered":"

ESTRO 36 will take place 5-9 May 2017 in Vienna, Austria.<\/strong><\/p>\n

ESTRO is an interdisciplinary society where radiation oncologists, medical physicists, radiobiologists, brachytherapists and radiation therapists aspire to join forces with other organisations in the oncology field that share ESTRO\u2019s vision of excellence in cancer treatment. At ESTRO 36, we draw attention to the multidisciplinary and interdisciplinary components of our practice, with emphasis on the new opportunities that they represent for all professionals of oncology, not only in research but also in the daily care of patients.<\/p>\n

The interdisciplinary component of the scientific programme will include sessions on the following topics:<\/p>\n

\u2022 MR guided radiotherapy: the new standard of care in 10 years time
\n\u2022 Radiomics and imaging databases for precision radiation oncology
\n\u2022 From big data to better radiotherapy
\n\u2022 Costs and value of radiotherapy innovations: how to assess
\n\u2022 Challenges in proton radiotherapy
\n\u2022 Is there any ground for boost brachytherapy in the time of high precision IGRT\/IMRT?
\n\u2022 Selection of patients and radiotherapy technique for APBI in the light of new phase III trial data
\n\u2022 Clinical evidence for hypofractionation in prostate cancer what is the optimum?
\n\u2022 Oligometastatic disease
\n\u2022 Radiotherapy plus immunotherapy combination: rationale and results so far
\n\u2022 Immunotherapy
\n\u2022 Targeting tumour heterogenveity
\n\u2022 Response adapted treatment
\n\u2022 Patient Reported Outcomes (PROs) in radiotherapy
\n\u2022 Safety and clinical and cost effectiveness of multi-modality IGRT and ART
\n\u2022 Clinical impact of waiting times
\n\u2022 Strategies to increase safety in radiation oncology: how to make accidents less likely to occur<\/p>\n

Meanwhile, the Scientific Programme Committee and Scientific Advisory Groups of ESTRO 36 work hard to develop an excellent multidisciplinary component for the scientific programme, a multidisciplinarity which will also be highlighted in several joint sessions with other European and international oncology societies.<\/p>\n

The educational aspects of ESTRO 36 will include pre-meeting courses, contouring workshops, teaching lectures and multidisciplinary tumour board sessions.<\/p>\n

As in previous conferences, ESTRO 36 will offer a Young Scientists Track. This track is fully organised by our young members and it enables them to meet young colleagues, share common interests, network and start to build their own collaborative projects at an international level.<\/p>\n

Last but not least, the ESTRO annual meetings can only become a successful scientific event due to the multitude of contributions coming via abstract submissions. The Scientific Programme Committee is committed to offering large visibility to promising abstracts by including them in the scientific symposia or via dedicated poster viewing sessions. We therefore strongly encourage you to take note of the abstract submission deadline and to send your abstracts in due time.<\/p>\n

All of the leading exhibitors will contribute to ESTRO 36, Europe\u2019s largest industrial exhibition in radiation oncology, offering the opportunity to view the latest radiotherapy technology and cancer treatment products.<\/p>\n

All information is copied\u00a0from\u00a0http:\/\/estro.org\/congresses-meetings\/articles\/estro-36-welcome-letter<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

ESTRO 36 will take place 5-9 May 2017 in Vienna, Austria. ESTRO is an interdisciplinary society where radiation oncologists, medical physicists, radiobiologists, brachytherapists and radiation therapists aspire to join forces with other organisations in the oncology field that share ESTRO\u2019s [\u2026]<\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[12],"tags":[],"class_list":["post-59","post","type-post","status-publish","format-standard","hentry","category-conferences"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/zfbweb.zfb.fuw.edu.pl\/index.php\/wp-json\/wp\/v2\/posts\/59","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zfbweb.zfb.fuw.edu.pl\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zfbweb.zfb.fuw.edu.pl\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zfbweb.zfb.fuw.edu.pl\/index.php\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/zfbweb.zfb.fuw.edu.pl\/index.php\/wp-json\/wp\/v2\/comments?post=59"}],"version-history":[{"count":6,"href":"https:\/\/zfbweb.zfb.fuw.edu.pl\/index.php\/wp-json\/wp\/v2\/posts\/59\/revisions"}],"predecessor-version":[{"id":842,"href":"https:\/\/zfbweb.zfb.fuw.edu.pl\/index.php\/wp-json\/wp\/v2\/posts\/59\/revisions\/842"}],"wp:attachment":[{"href":"https:\/\/zfbweb.zfb.fuw.edu.pl\/index.php\/wp-json\/wp\/v2\/media?parent=59"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zfbweb.zfb.fuw.edu.pl\/index.php\/wp-json\/wp\/v2\/categories?post=59"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zfbweb.zfb.fuw.edu.pl\/index.php\/wp-json\/wp\/v2\/tags?post=59"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}